Early-life factors contributing to type 1 diabetes

• Published in: Diabetologia Vol. 62; no. 10; pp. 1823 - 1834
• Main Authors: Craig, Maria E., Kim, Ki Wook, Isaacs, Sonia R., Penno, Megan A., Hamilton-Williams, Emma E., Couper, Jennifer J., Rawlinson, William D.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-10-2019; Springer Nature B.V
• Subjects: Autoantibodies; Autoimmunity; Beta cells; Body weight; Breast feeding; Children; Diabetes; Diabetes mellitus; Diabetes mellitus (insulin dependent); Environmental factors; Epidemiology; Fetuses; Genomes; Human Physiology; Immune system; Internal Medicine; Medicine; Medicine & Public Health; Metabolic Diseases; Microbiomes; Neonates; Overweight; Pancreas; Pregnancy; Review; Pregnancy; Virus; Diet; Type 1 diabetes; Life course development; Enterovirus; Gene–environment interaction; Review; Child; Microbiome
• ISSN: 0012-186X; 1432-0428
• DOI: 10.1007/s00125-019-4942-x

The incidence of type 1 diabetes has increased since the mid-twentieth century at a rate that is too rapid to be attributed to genetic predisposition alone. While the disease can occur at any age, mounting evidence from longitudinal cohort studies of at-risk children indicate that type 1 diabetes associated autoantibodies can be present from the first year of life, and that those who develop type 1 diabetes at a young age have a more aggressive form of the disease. This corroborates the hypothesis that environmental exposures in early life contribute to type 1 diabetes risk, whether related to maternal influences on the fetus during pregnancy, neonatal factors or later effects during infancy and early childhood. Studies to date show a range of environmental triggers acting at different time points, suggesting a multifactorial model of genetic and environmental factors in the pathogenesis of type 1 diabetes, which integrally involves a dialogue between the immune system and pancreatic beta cells. For example, breastfeeding may have a weak protective effect on type 1 diabetes risk, while use of an extensively hydrolysed formula does not. Additionally, exposure to being overweight pre-conception, both in utero and postnatally, is associated with increased risk of type 1 diabetes. Epidemiological, clinical and pathological studies in humans support a role for viral infections, particularly enteroviruses, in type 1 diabetes, but definitive proof is lacking. The role of the early microbiome and its perturbations in islet autoimmunity and type 1 diabetes is the subject of investigation in ongoing cohort studies. Understanding the interactions between environmental exposures and the human genome and metagenome, particularly across ethnically diverse populations, will be critical for the development of future strategies for primary prevention of type 1 diabetes.